Have you met anyone who preferred sickness over health or who given quality of life wanted to die before their time?
Breakthrough science brands redefine innovation
The pharmaceutical industry has always prided itself on its record of innovation and there have been numerous examples of medicines that fully support that claim.
Rare diseases, a sustainable opportunity?
Once a neglected area by the pharmaceutical industry, rare diseases are now very much on the radar with drugs in the category worth $50 billion worldwide.
Biosimilars, you ain’t seen nothing yet!
According to the IMS Institute, biologics account for 27% of the pharmaceutical sales in the EU and grew at at 5.5% vs. a total market growth of 1.9% between 2012 and 2013.